These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2858446)

  • 1. Overcoming resistance to talking to patients about tardive dyskinesia.
    Munetz MR
    Hosp Community Psychiatry; 1985 Mar; 36(3):283-7. PubMed ID: 2858446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention and management of tardive dyskinesia.
    Jeste DV; Wyatt RJ
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):14-8. PubMed ID: 2858473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CMHC practices related to tardive dyskinesia screening and informed consent for neuroleptic drugs.
    Benjamin S; Munetz MR
    Hosp Community Psychiatry; 1994 Apr; 45(4):343-6. PubMed ID: 7912689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for tardive dyskinesia.
    Munetz MR; Schulz SC
    J Clin Psychiatry; 1986 Feb; 47(2):75-7. PubMed ID: 2867994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tardive dyskinesia and informed consent: myths and realities.
    Munetz MR; Roth LH; Cornes CL
    Bull Am Acad Psychiatry Law; 1982; 10(2):77-88. PubMed ID: 6129012
    [No Abstract]   [Full Text] [Related]  

  • 6. Informed consent and tardive dyskinesia.
    Kleinman I; Schachter D; Koritar E
    Am J Psychiatry; 1989 Jul; 146(7):902-4. PubMed ID: 2568093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Informed consent for neuroleptic therapy.
    Deveaugh-Geiss J
    Am J Psychiatry; 1979 Jul; 136(7):959-62. PubMed ID: 36766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Legal aspects of tardive dyskinesia.
    Davis JM; Comaty J
    Encephale; 1988 Sep; 14 Spec No():257-61. PubMed ID: 2905653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overcoming institutional and community resistance to a tardive dyskinesia management program.
    Wolf ME; Brown P
    Hosp Community Psychiatry; 1987 Jan; 38(1):65-8. PubMed ID: 2879787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Informed consent and tardive dyskinesia. Long-term follow-up.
    Kleinman I; Schachter D; Jeffries J; Goldhamer P
    J Nerv Ment Dis; 1996 Sep; 184(9):517-22. PubMed ID: 8831640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Informing patients about tardive dyskinesia: four-year follow up of a trial of patient education.
    Chaplin R; Timehin C
    Aust N Z J Psychiatry; 2002 Feb; 36(1):99-103. PubMed ID: 11929445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychiatrists' attitudes about and informed consent practices for antipsychotics and tardive dyskinesia.
    Schachter DC; Kleinman I
    Psychiatr Serv; 2004 Jun; 55(6):714-7. PubMed ID: 15175474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of severe and mild tardive dyskinesia: implications for etiology.
    Gardos G; Cole JO; Schniebolk S; Salomon M
    J Clin Psychiatry; 1987 Sep; 48(9):359-62. PubMed ID: 2887550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Informing patients about tardive dyskinesia.
    Munetz MR; Roth LH
    Arch Gen Psychiatry; 1985 Sep; 42(9):866-71. PubMed ID: 2864030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tardive dyskinesia, impaired recall, and informed consent.
    Ganguli R; Raghu U
    J Clin Psychiatry; 1985 Oct; 46(10):434-5. PubMed ID: 2864333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Informing patients about tardive dyskinesia. Controlled trial of patient education.
    Chaplin R; Kent A
    Br J Psychiatry; 1998 Jan; 172():78-81. PubMed ID: 9534837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermittent neuroleptic therapy and tardive dyskinesia: a literature review.
    Goldman MB; Luchins DJ
    Hosp Community Psychiatry; 1984 Dec; 35(12):1215-9. PubMed ID: 6150891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of two methods for informing schizophrenic patients about neuroleptic medication.
    Kleinman I; Schachter D; Jeffries J; Goldhamer P
    Hosp Community Psychiatry; 1993 Dec; 44(12):1189-91. PubMed ID: 7907571
    [No Abstract]   [Full Text] [Related]  

  • 19. Neuroleptic drugs and tardive dyskinesia.
    Bittker TE
    Ariz Med; 1981 Sep; 38(9):708-9. PubMed ID: 6117266
    [No Abstract]   [Full Text] [Related]  

  • 20. [Medicolegal aspects of tardive dyskinesia in the United States].
    Wolf MA; Grunberg F; Garneau Y
    Encephale; 1988; 14(3):133-8. PubMed ID: 2900134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.